Paul Giannasca, VP of Development at GENOCEA BIOSCIENCES, INC. (GNCA), sold 4,071 shares at $11.84 ($48K) on 2014-09-11, disclosed to the SEC on 2014-09-15.
Open-market sale of $48k GNCA by VP of Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.